What Researchers Did
Researchers retrospectively compared outcomes in 55 patients with deep sternal wound infection after cardiac surgery: 22 received HBOT plus standard care, and 33 received standard care plus real-time fluorescent imaging (RTFI) for guided debridement.
What They Found
HBOT reduced in-hospital mortality compared to the non-HBOT baseline. The RTFI group showed superior infection control metrics including lower reinfection rates and shorter healing time. HBOT was specifically credited with mortality benefit.
What This Means for Canadian Patients
Deep sternal wound infection after open heart surgery is a life-threatening complication. HBOT appears to reduce mortality in this context. Canadian cardiac surgery centers should consider integrating HBOT access into their wound complication protocols for post-sternotomy infections.
Canadian Relevance
No direct Canadian connection identified, though the MolecuLight imaging device used in this study is a Canadian product (MolecuLight Inc., Toronto).
Study Limitations
The retrospective design with different patient groups receiving different additional interventions makes it difficult to isolate HBOT independent contribution to mortality reduction.